Victory Capital Management Inc Bio Rad Laboratories, Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

A detailed history of Victory Capital Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 21,108 shares of BIO stock, worth $7.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,108
Previous 17,810 18.52%
Holding current value
$7.01 Million
Previous $6.16 Million 6.41%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
BUY
$268.26 - $339.48 $884,721 - $1.12 Million
3,298 Added 18.52%
21,108 $5.76 Million
Q1 2024

May 03, 2024
BUY
$304.11 - $351.99 $42,271 - $48,926
139 Added 0.79%
17,810 $6.16 Million
Q4 2023

Feb 05, 2024
BUY
$269.37 - $365.04 $1.56 Million - $2.11 Million
5,790 Added 48.73%
17,671 $5.71 Million
Q3 2023

Nov 06, 2023
SELL
$350.25 - $422.63 $313,473 - $378,253
-895 Reduced 7.01%
11,881 $4.26 Million
Q2 2023

Jul 27, 2023
BUY
$359.49 - $486.4 $2.26 Million - $3.05 Million
6,273 Added 96.46%
12,776 $4.84 Million
Q1 2023

May 02, 2023
SELL
$418.69 - $503.0 $1.74 Million - $2.09 Million
-4,162 Reduced 39.02%
6,503 $3.12 Million
Q4 2022

Feb 10, 2023
SELL
$351.71 - $456.01 $36,226 - $46,969
-103 Reduced 0.96%
10,665 $4.49 Million
Q4 2022

Feb 09, 2023
BUY
$351.71 - $456.01 $1.02 Million - $1.32 Million
2,898 Added 36.82%
10,768 $4.53 Million
Q3 2022

Nov 02, 2022
SELL
$412.59 - $563.26 $1.83 Million - $2.5 Million
-4,438 Reduced 36.06%
7,870 $3.28 Million
Q2 2022

Aug 01, 2022
SELL
$463.67 - $597.16 $217,924 - $280,665
-470 Reduced 3.68%
12,308 $6.09 Million
Q1 2022

May 04, 2022
SELL
$524.57 - $735.42 $105,438 - $147,819
-201 Reduced 1.55%
12,778 $6.56 Million
Q4 2021

Feb 07, 2022
BUY
$708.84 - $794.68 $8,506 - $9,536
12 Added 0.09%
12,979 $9.81 Million
Q3 2021

Nov 02, 2021
SELL
$657.71 - $825.77 $388,706 - $488,030
-591 Reduced 4.36%
12,967 $9.67 Million
Q2 2021

Aug 03, 2021
SELL
$576.64 - $649.04 $2.39 Million - $2.69 Million
-4,152 Reduced 23.44%
13,558 $8.74 Million
Q1 2021

May 04, 2021
SELL
$547.01 - $662.35 $6.87 Million - $8.32 Million
-12,558 Reduced 41.49%
17,710 $10.1 Million
Q4 2020

Feb 01, 2021
SELL
$510.68 - $643.45 $403,947 - $508,968
-791 Reduced 2.55%
30,268 $17.6 Million
Q3 2020

Nov 09, 2020
BUY
$454.43 - $535.6 $7.84 Million - $9.24 Million
17,248 Added 124.89%
31,059 $16 Million
Q2 2020

Aug 07, 2020
SELL
$334.87 - $493.06 $2.35 Million - $3.45 Million
-7,006 Reduced 33.66%
13,811 $6.24 Million
Q1 2020

May 04, 2020
BUY
$320.01 - $409.07 $780,184 - $997,312
2,438 Added 13.27%
20,817 $7.3 Million
Q4 2019

Feb 06, 2020
BUY
$319.73 - $374.2 $459,132 - $537,351
1,436 Added 8.48%
18,379 $6.8 Million
Q4 2019

Feb 04, 2020
SELL
$319.73 - $374.2 $827,461 - $968,429
-2,588 Reduced 13.25%
16,943 $6.12 Million
Q3 2019

Nov 12, 2019
BUY
$304.55 - $345.24 $3.56 Million - $4.03 Million
11,676 Added 148.64%
19,531 $6.5 Million
Q2 2019

Aug 15, 2019
BUY
$286.93 - $312.59 $2.25 Million - $2.46 Million
7,855 New
7,855 $2.46 Million
Q1 2019

May 03, 2019
SELL
$224.3 - $317.41 $2.55 Million - $3.61 Million
-11,385 Closed
0 $0
Q4 2018

Feb 05, 2019
SELL
$220.1 - $309.0 $11,665 - $16,377
-53 Reduced 0.46%
11,385 $2.64 Million
Q3 2018

Nov 01, 2018
BUY
$289.28 - $326.15 $924,249 - $1.04 Million
3,195 Added 38.76%
11,438 $3.58 Million
Q2 2018

Aug 02, 2018
BUY
$244.1 - $303.88 $228,721 - $284,735
937 Added 12.83%
8,243 $2.38 Million
Q1 2018

May 04, 2018
BUY
$233.97 - $274.11 $1.71 Million - $2 Million
7,306 New
7,306 $1.83 Million

Others Institutions Holding BIO

# of Institutions
461
Shares Held
19.6M
Call Options Held
23.2K
Put Options Held
37.4K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.18B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email